Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FirstEnergy
FE
|
+$185M |
| 2 |
Tyson Foods
TSN
|
+$177M |
| 3 |
Procter & Gamble
PG
|
+$110M |
| 4 |
Entergy
ETR
|
+$101M |
| 5 |
ENDP
Endo International plc
ENDP
|
+$95.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$129M |
| 2 |
Apple
AAPL
|
+$107M |
| 3 |
Abbott
ABT
|
+$99.3M |
| 4 |
AGN
Allergan plc
AGN
|
+$88.8M |
| 5 |
Goldman Sachs
GS
|
+$88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Financials | 13.34% |
| 3 | Industrials | 12.76% |
| 4 | Consumer Discretionary | 12.72% |
| 5 | Consumer Staples | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTB
1926
HomeTrust Bancshares
HTB
$773M
| $422K | ﹤0.01% |
+22,822
| New | +$426K |
|
|
CNCE
1927
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $421K | ﹤0.01% |
37,469
-29,317
| -44% | -$373K |
|
|
CVGW
1928
DELISTED
Calavo Growers
CVGW
| $420K | ﹤0.01% |
6,272
| – | – |
|
1929
HCI Group
HCI
$2.31B
| $418K | ﹤0.01% |
15,310
+4,333
| +39% | +$133K |
|
1930
Hancock Whitney
HWC
$6.06B
| $417K | ﹤0.01% |
15,960
-72,773
| -82% | -$1.85M |
|
|
GBL
1931
DELISTED
GAMCO Investors, Inc.
GBL
| $412K | ﹤0.01% |
12,554
-4,457
| -26% | -$163K |
|
1932
The Ensign Group
ENSG
$10.4B
| $410K | ﹤0.01% |
20,848
-22,305
| -52% | -$445K |
|
|
NVEE
1933
DELISTED
NV5 Global
NVEE
| $410K | ﹤0.01% |
57,684
-37,180
| -39% | -$251K |
|
1934
Graco
GGG
$13.1B
| $409K | ﹤0.01% |
+15,543
| New | +$418K |
|
|
RT
1935
DELISTED
Ruby Tuesday Georgia
RT
| $409K | ﹤0.01% |
113,407
+13,048
| +13% | +$55.2K |
|
1936
Sasol
SSL
$8B
| $407K | ﹤0.01% |
15,003
-1,104
| -7% | -$32.5K |
|
|
BPFH
1937
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $405K | ﹤0.01% |
34,358
+7,133
| +26% | +$85.9K |
|
|
SGBK
1938
DELISTED
Stonegate Bank
SGBK
| $404K | ﹤0.01% |
12,526
-9,864
| -44% | -$307K |
|
1939
Community Trust Bancorp
CTBI
$1.41B
| $402K | ﹤0.01% |
11,607
+53
| +0.5% | +$1.88K |
|
1940
Globalstar
GSAT
$10.6B
| $400K | ﹤0.01% |
22,042
+7,407
| +51% | +$197K |
|
1941
Puma Biotechnology
PBYI
$469M
| $399K | ﹤0.01% |
13,410
+3,513
| +35% | +$110K |
|
|
NXTM
1942
DELISTED
NxStage Medical Inc.
NXTM
| $399K | ﹤0.01% |
18,387
-12,338
| -40% | -$220K |
|
|
WIBC
1943
DELISTED
WILSHIRE BANCORP INC
WIBC
| $398K | ﹤0.01% |
38,200
| – | – |
|
1944
TTM Technologies
TTMI
$11.1B
| $396K | ﹤0.01% |
52,545
-45,084
| -46% | -$319K |
|
1945
Iridium Communications
IRDM
$5.11B
| $395K | ﹤0.01% |
44,495
| – | – |
|
1946
Tenaris
TS
$26.8B
| $394K | ﹤0.01% |
13,648
-674
| -5% | -$17.9K |
|
1947
Qualys
QLYS
$6.27B
| $393K | ﹤0.01% |
13,182
-245
| -2% | -$6.88K |
|
|
ADVM
1948
DELISTED
Adverum Biotechnologies
ADVM
| $392K | ﹤0.01% |
12,395
+1,922
| +18% | +$86.8K |
|
1949
Goldgroup Mining
GORO
$248M
| $390K | ﹤0.01% |
+108,542
| New | +$343K |
|
1950
MDU Resources
MDU
$4.19B
| $389K | ﹤0.01% |
+42,588
| New | +$347K |
|
Similar funds
Cliff Asness's Q2 2016 Portfolio in Review
As of Q2 2016, Cliff Asness held 2,362 positions worth $56.7B, up 1.9% from $55.6B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Cliff Asness's Q2 2016 filing shows 158 new, 1,005 increased, 951 reduced and 174 closed positions. Its largest new stake was S&P Global: 466,444 shares worth $50M. The largest sale was Nike, an estimated $129M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.
- Cliff Asness's largest Q2 2016 buy was S&P Global: 466,444 shares worth $50M.
- Cliff Asness added most to FirstEnergy in Q2 2016, an estimated $185M increase.
- Cliff Asness's biggest Q2 2016 reduction was Nike, cutting an estimated $129M.
- Cliff Asness fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $59.8M.
- Cliff Asness's ten largest holdings make up 8.7% of its $56.7B portfolio in Q2 2016.
- Cliff Asness opened 158 new positions and closed 174 in Q2 2016.
- Cliff Asness's portfolio value rose 1.9% quarter-over-quarter to $56.7B.
Based on AQR Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.